TIARA ESANI: Open Payments
NPI 1902130842 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 12 payments from 6 companies in 2025. Trend: 2023 $117 · 2024 $58 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $28 |
| BioWound Solutions, Inc. | 2 | $19 |
| Organon LLC | 1 | $11 |
Products named: SHINGRIX, REXULTI, TRELEGY ELLIPTA, MOUNJARO, bio-ConneKt, NEXPLANON.
Industry payments across CA — which companies pay providers there.
